These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9874704)

  • 21. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the behavior of HPMC/Theophylline matrices for controlled drug delivery.
    Barba AA; d'Amore M; Cascone S; Chirico S; Lamberti G; Titomanlio G
    J Pharm Sci; 2009 Nov; 98(11):4100-10. PubMed ID: 19226633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Jan; 77(1):99-110. PubMed ID: 21081160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.
    Saurí J; Millán D; Suñé-Negre JM; Colom H; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
    Int J Pharm; 2014 Dec; 477(1-2):431-41. PubMed ID: 25445523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synchrotron X-ray microtomographic study of tablet swelling.
    Laity PR; Cameron RE
    Eur J Pharm Biopharm; 2010 Jun; 75(2):263-76. PubMed ID: 20172028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New comprehensive mathematical model for HPMC-MCC based matrices to design oral controlled release systems.
    Saeidipour F; Mansourpour Z; Mortazavian E; Rafiee-Tehrani N; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2017 Dec; 121():61-72. PubMed ID: 28951063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymer erosion and drug release characterization of hydroxypropyl methylcellulose matrices.
    Reynolds TD; Gehrke SH; Hussain AS; Shenouda LS
    J Pharm Sci; 1998 Sep; 87(9):1115-23. PubMed ID: 9724564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine.
    Nie S; Pan W; Li X; Wu X
    Drug Dev Ind Pharm; 2004 Jul; 30(6):627-35. PubMed ID: 15285336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and behavior in hydrophilic matrix sustained release dosage forms: 4. Studies of water mobility and diffusion coefficients in the gel layer of HPMC tablets using NMR imaging.
    Rajabi-Siahboomi AR; Bowtell RW; Mansfield P; Davies MC; Melia CD
    Pharm Res; 1996 Mar; 13(3):376-80. PubMed ID: 8692728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of water mobility and diffusivity in hydrating micronized low-substituted hydroxypropyl cellulose, hydroxypropylmethyl cellulose, and hydroxypropyl cellulose matrix tablets by magnetic resonance imaging (MRI).
    Kojima M; Nakagami H
    Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1621-4. PubMed ID: 12499605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compressed mini-tablets as a biphasic delivery system.
    Lopes CM; Lobo JM; Pinto JF; Costa P
    Int J Pharm; 2006 Oct; 323(1-2):93-100. PubMed ID: 16828999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. III. Critical use of thermodynamic parameters of activation for modeling the water penetration and drug release processes.
    Ferrero C; Massuelle D; Jeannerat D; Doelker E
    J Control Release; 2013 Sep; 170(2):175-82. PubMed ID: 23727289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of physicochemical properties of hydroxypropyl methylcellulose (HPMC) type 2208 and their influence on prolonged drug release from matrix tablets.
    Devjak Novak S; Šporar E; Baumgartner S; Vrečer F
    J Pharm Biomed Anal; 2012 Jul; 66():136-43. PubMed ID: 22510313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the film-coating properties of a hydroxyethyl cellulose/hydroxypropyl methylcellulose polymer system.
    Li SP; Martellucci SA; Bruce RD; Kinyon AC; Hay MB; Higgins JD
    Drug Dev Ind Pharm; 2002 Apr; 28(4):389-401. PubMed ID: 12056532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of dividable one-step dry-coated tablets (dividable-OSDRC) and their evaluation as a new platform for controlled drug release.
    Ozeki Y; Watanabe Y; Okamoto H; Danjo K
    Pharm Res; 2004 Jul; 21(7):1177-83. PubMed ID: 15290857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration.
    Fu XC; Wang GP; Liang WQ; Chow MS
    J Control Release; 2004 Mar; 95(2):209-16. PubMed ID: 14980769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion in HPMC gels. I. Determination of drug and water diffusivity by pulsed-field-gradient spin-echo NMR.
    Gao P; Fagerness PE
    Pharm Res; 1995 Jul; 12(7):955-64. PubMed ID: 7494815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxypropyl methylcellulose mixtures: effects and kinetics of release of an insoluble drug.
    Eyjolfsson R
    Drug Dev Ind Pharm; 1999 May; 25(5):667-9. PubMed ID: 10219537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
    Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.